학술논문
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Document Type
Article
Author
Ghaneh, P.; Palmer, D.; Cicconi, S.; Jackson, R.; Halloran, C.M.; Rawcliffe, C.; Neoptolemos, J.P.; Sripadam, R.; Mukherjee, S.; Soonawalla, Z.; Wadsley, J.; Al-Mukhtar, A.; Dickson, E.; Graham, J.; Jiao, L.; Wasan, H.S.; Tait, I.S.; Prachalias, A.; Ross, P.; Valle, J.W.; O'Reilly, D.A.; Al-Sarireh, B.; Gwynne, S.; Ahmed, I.; Connolly, K.; Yim, K.-L.; Cunningham, D.; Armstrong, T.; Archer, C.; Roberts, K.; Ma, Y.T.; Springfeld, C.; Tjaden, C.; Hackert, T.; Büchler, M.W.
Source
In: The Lancet Gastroenterology and Hepatology . (The Lancet Gastroenterology and Hepatology, February 2023, 8(2):157-168)
Subject
Language
English
ISSN
24681253